Most cited papers from Hospital de Sant Pau

Hospital de Sant Pau

What are the most cited papers from Hospital de Sant Pau?

The most cited paper from Hospital de Sant Pau is "GRADE: an emerging consensus on rating quality of evidence and strength of recommendations" (Gordon Henry Guyatt, Andrew David Oxman, Gunn Elisabeth Vist et al., 2008), with 23,388 citations. Next come "Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" (9,055) and "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" (8,461).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 1,059 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	GRADE: an emerging consensus on rating quality of evidence and strength of recommendations Gordon Henry Guyatt, Andrew David Oxman, Gunn Elisabeth Vist et al. · BMJ Open access	24 Apr 2008	23,388
2	Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Christopher J L Murray et al. · The Lancet Open access362 authors	Dec 2012	9,055
3	Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Theo Vos et al. · The Lancet Open access358 authors	Dec 2012	8,461
4	Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results Christopher G. Goetz et al. · Movement Disorders Open access	15 Nov 2008	7,783
5	Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial Roy S. Herbst, Paul Baas, Dong‐Wan Kim et al. · The Lancet	19 Dec 2015	6,590
6	Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel Hartmut Döhner et al. · Blood Open access	28 Nov 2016	5,972
7	Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial Rafael Rosell et al. · The Lancet Oncology Open access	30 Jan 2012	5,563
8	2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk François Mach et al. · Atherosclerosis Open access100 authors	31 Aug 2019	4,890
9	Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease European Alzheimer's Disease Initiative (EADI) et al. · Nature Genetics ReviewOpen access184 authors	27 Oct 2013	4,711
10	Prone Positioning in Severe Acute Respiratory Distress Syndrome Claude Guérin et al. · New England Journal of Medicine Open access	20 May 2013	4,142
11	Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hartmut Döhner, Elihu H. Estey, Sergio Amadori et al. · Blood Open access	30 Oct 2009	3,422
12	Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN Hartmut Döhner et al. · Blood Open access	7 Jul 2022	3,286
13	Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing Brian W. Kunkle et al. · Nature Genetics ReviewOpen access469 authors	28 Feb 2019	3,277
14	Atherosclerosis Peter Libby, Julie E. Buring, Lina Badimón et al. · Nature Reviews Disease Primers Review	16 Aug 2019	3,145
15	International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Daniel A. Arber et al. · Blood Open access	29 Jun 2022	2,906
16	GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias) Gordon Henry Guyatt, Andrew David Oxman, Gunn Elisabeth Vist et al. · Journal of Clinical Epidemiology	24 Jan 2011	2,894
17	Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Silvia de Sanjosé et al. · The Lancet Oncology	18 Oct 2010	2,774
18	GRADE guidelines 6. Rating the quality of evidence—imprecision Gordon Henry Guyatt, Andrew David Oxman, Regina Kunz et al. · Journal of Clinical Epidemiology	15 Aug 2011	2,755
19	New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez et al. · Nature Genetics Open access1,266 authors	Apr 2022	2,608
20	Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster et al. · Movement Disorders Open access	24 Jan 2012	2,583
21	GRADE guidelines: 7. Rating the quality of evidence—inconsistency Gordon Henry Guyatt, Andrew David Oxman, Regina Kunz et al. · Journal of Clinical Epidemiology	6 Aug 2011	2,417
22	Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer Rafael Rosell et al. · New England Journal of Medicine Open access	19 Aug 2009	2,388
23	Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation Richard Maury Stone et al. · New England Journal of Medicine Open access	23 Jun 2017	2,258
24	Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Christina Davies et al. · The Lancet Open access	5 Dec 2012	2,067
25	Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Laurent Brochard, Jordi Mancebo, Marc Wysocki et al. · New England Journal of Medicine Open access	28 Sep 1995	2,060
26	Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials Richard G B Langley, Boni Elizabeth Elewski, Mark Lebwohl et al. · New England Journal of Medicine Open access	9 Jul 2014	2,004
27	Summary and Recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus Boyd E. Metzger, Thomas A. Buchanan, Donald R. Coustan et al. · Diabetes Care	27 Jun 2007	1,919
28	GRADE guidelines: 8. Rating the quality of evidence—indirectness Gordon Henry Guyatt, Andrew David Oxman, Regina Kunz et al. · Journal of Clinical Epidemiology Open access	26 Oct 2011	1,895
29	GRADE guidelines: 5. Rating the quality of evidence—publication bias Gordon Henry Guyatt, Andrew David Oxman, Víctor M. Montori et al. · Journal of Clinical Epidemiology	27 Oct 2011	1,872
30	Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine Open access	13 Feb 2021	1,811
31	Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer Yi-Long Lung Cancer Wu et al. · New England Journal of Medicine Open access	19 Sep 2020	1,809
32	Transfusion Strategies for Acute Upper Gastrointestinal Bleeding Càndid Villanueva, Alan Colomo, Alba Fernández Bosch et al. · New England Journal of Medicine Open access	2 Jan 2013	1,748
33	Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure Bram N. Rochwerg, Laurent Brochard, Mark Elliott et al. · European Respiratory Journal Open access	Aug 2017	1,690
34	Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia Willemijn J. Jansen et al. · JAMA Open access129 authors	19 May 2015	1,662
35	Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis Pau Sort, Miquel Navasa, Vicente Arroyo et al. · New England Journal of Medicine Open access	5 Aug 1999	1,658
36	Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia John C. Byrd et al. · New England Journal of Medicine Open access	31 May 2014	1,649
37	A Comparison of Four Methods of Weaning Patients from Mechanical Ventilation Andrés Esteban, Fernando Frutos–Vivar, Martin J. Tobin et al. · New England Journal of Medicine	9 Feb 1995	1,575
38	Prediction of Postoperative Pulmonary Complications in a Population-based Surgical Cohort Jaume Canet, L. Gallart, Carmen Guiralt Gomar et al. · Anesthesiology Open access	2 Nov 2010	1,518
39	Propagation of Tau Pathology in a Model of Early Alzheimer's Disease Alix de Calignon, Manuela Polydoro, Marc Suárez‐Calvet et al. · Neuron Open access	Feb 2012	1,470
40	Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan Christopher G. Goetz et al. · Movement Disorders Open access	17 Nov 2006	1,425
41	Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies Michel Wassef, Francine Blei, Denise M. Adams et al. · PEDIATRICS	10 Jun 2015	1,425
42	Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease Valentina Escott‐Price et al. · PLoS ONE Open access188 authors	12 Jun 2014	1,408
43	Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis Gerard Urrútia, Xavier Bonfill · Medicina Clínica	8 Mar 2010	1,378
44	Staging classification for cancer of the ovary, fallopian tube, and peritoneum Jaime Prat · International Journal of Gynecology & Obstetrics Open access	22 Oct 2013	1,372
45	GRADE guidelines: 9. Rating up the quality of evidence Gordon Henry Guyatt, Andrew David Oxman, Shahnaz Sultan et al. · Journal of Clinical Epidemiology	4 Aug 2011	1,357
46	GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength Jeffrey Campbell Andrews, Holger Jens Schünemann, Andrew David Oxman et al. · Journal of Clinical Epidemiology Open access	6 Apr 2013	1,323
47	Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort Luca Gianni, Wolfgang EIERMANN, Владимир Федорович Семиглазов et al. · The Lancet	2010	1,276
48	Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma Toni K. Choueiri et al. · New England Journal of Medicine Open access	25 Sep 2015	1,248
49	Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 cases Cristina Galván‐Casas et al. · British Journal of Dermatology Open access	29 Apr 2020	1,242
50	Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors Manel Esteller · JNCI Journal of the National Cancer Institute	5 Apr 2000	1,238

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.